You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CK-2127107

Showing 1 - 25 of 162
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD (COPD) Trial in Torrance, Pittsburgh (Reldesemtiv, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Torrance, California
  • +1 more
Feb 26, 2021

Mobility Limitation Trial in United States (reldesemtiv, Placebo)

Terminated
  • Mobility Limitation
  • Gainesville, Florida
  • +4 more
Nov 16, 2020

Spinal Muscular Atrophy Trial in Canada, United States (Placebo, Reldesemtiv 150 mg, Reldesemtiv 450 mg)

Completed
Has Results
  • Spinal Muscular Atrophy
  • Placebo
  • +2 more
  • Los Angeles, California
  • +18 more
Aug 21, 2020

Amyotrophic Lateral Sclerosis Trial in Worldwide (Reldesemtiv, Placebo)

Completed
Has Results
  • Amyotrophic Lateral Sclerosis
  • Phoenix, Arizona
  • +63 more
Aug 21, 2020

Amyotrophic Lateral Sclerosis Trial in Fredericton, Montréal (Reldesemtiv)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Fredericton, New Brunswick, Canada
  • +1 more
Aug 9, 2022

Amyotrophic Lateral Sclerosis Trial in Worldwide (Reldesemtiv, Placebo)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Phoenix, Arizona
  • +82 more
Jan 6, 2023

Healthy Participants Trial in Tempe (CK-4021586, Placebo for CK-4021586)

Recruiting
  • Healthy Participants
  • Tempe, Arizona
    Celerion
May 17, 2023

Healthy Participants Trial in Dallas (CK-3828136, Placebo for CK-3828136)

Recruiting
  • Healthy Participants
  • Dallas, Texas
    Labcorp Clinical Research Unit Inc.
Dec 20, 2022

Symptomatic Hypertrophic Cardiomyopathy (HCM) Trial in Italy, Spain, United States (CK-3773274 (5 - 20 mg))

Enrolling by invitation
  • Symptomatic Hypertrophic Cardiomyopathy (HCM)
  • CK-3773274 (5 - 20 mg)
  • Los Angeles, California
  • +18 more
Jan 31, 2023

Lung Tumors, NSCLC, Lung Diseases Trial in Worldwide (CK-101)

Completed
  • Lung Neoplasms
  • +3 more
  • Sarasota, Florida
  • +19 more
Jul 25, 2022

Healthy Trial in Edegem (CK-0045, Placebo)

Recruiting
  • Healthy
  • Edegem, Belgium
    SGS Clinical Research, Clinical Pharmacology Unit
Jan 26, 2023

Gastrointestinal Tumors Trial in Beijing (AZD6422 CLDN18.2 CAR-T product)

Not yet recruiting
  • Gastrointestinal Tumors
  • AZD6422 CLDN18.2 CAR-T product
  • Beijing, China
    Beijing Cancer Hospital
Aug 1, 2023

Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy (oHCM)
  • Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
  • +3 more
  • (no location specified)
Mar 2, 2023

Diagnostic Test Trial in Sacramento (Measuring of analytes)

Recruiting
  • Diagnostic Test
  • Measuring of analytes
  • Sacramento, California
    UC Davis
Oct 9, 2023

Total Knee Arthroplasty Trial in France (Total Knee arthroplasty)

Not yet recruiting
  • Total Knee Arthroplasty
  • Total Knee arthroplasty
  • Beaumont, France
  • +4 more
Nov 8, 2023

Acute Myeloid Leukemia Trial in United Kingdom, United States (Arm 1: NTLA-5001, Arm 2: NTLA-5001)

Terminated
  • Acute Myeloid Leukemia
  • Arm 1: NTLA-5001
  • Arm 2: NTLA-5001
  • Los Angeles, California
  • +9 more
Oct 13, 2022

Rejection in Liver Transplant Patients

Active, not recruiting
  • Liver Transplant Rejection
  • Liver Transplant Failure and Rejection
  • N/A-Observational Study
  • Saint Louis, Missouri
    SSM Health Cardinal Glennon Children's Hospital & Saint Louis Un
Nov 29, 2023

Bone Intake Proteins and Muscle Mass Deficiency in Proximal

Completed
  • Femoral Neck Fractures
  • +5 more
  • Surgical treatment of proximal femur fracture and blood sample test
  • Blood sample test
  • Warsaw, Poland
    Department of Othopedics and Rehabilitation, Medical University
Mar 26, 2023

Muscle Injury Trial in Dublin (Elio, Placebo)

Completed
  • Muscle Injury
  • Elio
  • Placebo
  • Dublin, Leinster, Ireland
    Nuritas Ltd
May 5, 2022

Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial in Worldwide (CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

Recruiting
  • Obstructive Hypertrophic Cardiomyopathy (oHCM)
  • CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg)
  • Placebo to match CK-3773274
  • Anchorage, Alaska
  • +31 more
Aug 9, 2022

Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS

Withdrawn
  • Brain and Nervous System
    • (no location specified)
    Jan 20, 2022

    Lung Tumors, NSCLC, Carcinoma, Small Cell Trial in Worldwide (CK-301 (cosibelimab))

    Recruiting
    • Lung Neoplasms
    • +12 more
    • CK-301 (cosibelimab)
    • Wollongong, New South Wales, Australia
    • +47 more
    Mar 3, 2022

    Hypertrophic Cardiomyopathy (HCM) Trial in Worldwide (CK-3773274 (5 - 15 mg), CK-3773274 (10 - 30 mg), Placebo for CK-3773274)

    Recruiting
    • Hypertrophic Cardiomyopathy (HCM)
    • CK-3773274 (5 - 15 mg)
    • +2 more
    • Los Angeles, California
    • +21 more
    Mar 4, 2022

    Obstructive Hypertrophic Cardiomyopathy, Healthy Adult Subjects Trial in Beijing (CK-3773274, Placebo)

    Completed
    • Obstructive Hypertrophic Cardiomyopathy
    • Healthy Adult Subjects
    • Beijing, Beijing, China
      Clinical Site
    Sep 12, 2021

    Cold-water Immersion, Protein-carbohydrates Supplementation, Active Recovery Trial in Puerto Real (Cold-water immersion,

    Completed
    • Cold-water Immersion
    • +3 more
    • Cold-water immersion
    • +3 more
    • Puerto Real, Cadiz, Spain
      Science of Education Faculty
    Mar 27, 2023